Plant Derived Recombinant Human Lactoferrin LF For Control Fe Concentration

Plant Derived Recombinant Human Lactoferrin For Control Fe Concentration​

Description

Recombinant human Lactoferrin (LF), also known as lactotransferrin (LTF), is a globular glycoprotein with a molecular mass of about 80kD, which consists of two highly homologous lobes, designated the N and C lobes. Each LF molecule can reversibly bind two ions of iron. LF is a member of the transferrin family that transfer iron to the cells and control the level of free iron in the blood and external secretions. It also has antibacterial, antiviral, antiparasitic, anti-cancer, anti-allergic and radioprotecting functions and properties. LF acts as an important component in body immune system.

Quick detail

1. CAS No.: 146897-68-9
2. Other Names: Recombinan LTF, Plant-derived lactoferrin, recombinant lactoferrin, OsrhLF, rhLF, rLf, recombinant hLF, rec Lf
3. Place of Origin: Wuhan, China (Mainland)
4. Brand Name: Oryzogen
5. Physical Appearance: Russetish lyophilized powder
6. Formulation: OsrhLF is lyophilized with inorganic salt
7. Endotoxin: Less than 20 EU/mg
8. Storage and Handling: Stored at temperatures 2-8℃ for 48 months

Advantages 

1. Wuhan Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development. Healthgen Biotech has strong capability in developing a series of biological products.

2. The chairman of Healthgen Biotech Professor Daichang.Yang is one of China's chief scientists. Professor Yang has rechieved the “Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province and Top 10 "Venture Eagle" entrepreneurs.

With years of effort, Healthgen Biotech has developed the State-of-the-Art platform called Oryz^HiExp, having high capacity to express no animal origin proteins and peptides in the rice endosperm cells.

3. Healthgen Biotech recombinant human Lactoferrin (OsrhLF) has excellent batch consistency. Using self-pollination rice as the bioreactor to express the OsrhLF, with the world's advanced facility and top production proceeding to extract and purify the OsrhLF, Healthgen Biotech can ensure the excellent consistency of OsrhLF from different batches.

Supplemental Description

Achievement and Honor

Healthgen Biotech obtained a number of patented technologies with independent intellectual property rights, including applied 9 national patents and 6 authorized patents, applied 7 international patents and 3 authorized patents. The international patents cover to United States, Japan, Europe and Canada. Moreover, two patents were authorized both by the Republic of South Africa and the United States. Based on rice endosperm specific expression technical platform-Oryz^HiExp, Healthgen Biotech, aim at the international forefront, takes the market as the orientation and enhances biotechnology innovation and engineering research, has won numerous awards.

Scientific Research Projects:

Major projects for New Drug Discovery, 3 projects of "Major projects of new varieties of genetically modified organisms” of the Ministry of Agriculture, National Ministry of Science and high Technology “863 plan”, National Ministry of Science and Technology Innovation fund, Pilot development of strategic emerging industries project

Talents Scheme:

“Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province, "3551 talents program” of the East Lake high-technology development zone , Top 10 "Venture Eagle" entrepreneurs.

Research Centers and Awards:

Wuhan National Biological Industry Base protein purification center, Hubei Molecular Biopharmaceutical Engineering Research Center, 2013 National Science and Technology Invention Award, 2012 Hubei Provincial Science and Technology Invention Award, 2013 China Patent Excellence Award, High-tech enterprise, Agricultural science and technology enterprise, Patent advantage enterprise.